Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 20Unknown 4Terminated 3Recruiting 3Enrolling by invitation 2Active not recruiting 2Withdrawn 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 3Thoracic 2Other solid neoplasm 1Myeloid 1

Conditions

Lymphoma 370Lymphoma, Non-Hodgkin 348Leukemia, Lymphocytic, Chronic, B-Cell 322Precursor Cell Lymphoblastic Leukemia-Lymphoma 291Lymphoma, Large B-Cell, Diffuse 244Lymphoma, Follicular 236Leukemia 198Hodgkin Disease 171Lymphoma, Mantle-Cell 164Leukemia, Myeloid, Acute 160Multiple Myeloma 134Myelodysplastic Syndromes 130Recurrence 125Burkitt Lymphoma 123Lymphoma, B-Cell, Marginal Zone 120Lymphoma, T-Cell, Cutaneous 92Neoplasms 82Mycosis Fungoides 82Lymphoma, B-Cell 82Waldenstrom Macroglobulinemia 74Leukemia, Myelogenous, Chronic, BCR-ABL Positive 70Sezary Syndrome 67Lymphoma, Large-Cell, Immunoblastic 65Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 57Lymphoma, Large-Cell, Anaplastic 54Neoplasms, Plasma Cell 52Myeloproliferative Disorders 52Primary Myelofibrosis 46Hematologic Neoplasms 44Blast Crisis 43

Interventions

NVP-QAV680 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Asthma × Lymphoid × Clear all
NCT02872298 2022-04-12

RELIEF-1

Nuvaira, Inc.

Phase NA Terminated
2 enrolled
Lymphoid

Asthma, Lymphoma, Follicular

NCT01103037 2020-12-19

Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

Novartis

Phase 2 Terminated
8 enrolled
Lymphoid

Asthma, Lymphoma, Follicular

NCT00721097 2013-09-30

EXPRESA

Nantes University Hospital

Terminated
40 enrolled
Lymphoid

Asthma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡